Clinical TrialKetamineKetamineCompleted

Ketamine Psychotherapy for Heroin Addiction: Double-Blind Dose-Comparison RCT (Krupitsky 2002, Leningrad Regional Centre of Addictions)

Double-blind randomised dose-comparison trial (J Subst Abuse Treat 2002; Krupitsky E, Burakov A, Romanova T, Dunaevsky I; Leningrad Regional Centre of Addictions, St. Petersburg, Russia; PMID 12495789). Participants: n=70 detoxified heroin-dependent inpatients randomised 1:1 to high-dose (n=35, 2.0 mg/kg IM ketamine) or low-dose active placebo (n=35, 0.20 mg/kg IM ketamine; sub-psychedelic). Both psychotherapist and subject blind to dose allocation; independent blinded rater assessed outcomes. Ketamine administered as part of a structured psychotherapy programme. 2-year follow-up for relapse/sobriety. Study submitted Dec 2002 — pre-dates the ICMJE 2005 prospective registration mandate. CT.gov: 0 hits; PubMed DataBankList: empty.

Target Enrollment
70 participants
Study Type
interventional
Design
Randomized, double Blind

Study Arms & Interventions

High dose ketamine

experimental

Existentially oriented psychotherapy in combination with a hallucinogenic (psychedelic) dose of ketamine.

Interventions

  • Ketamine2 mg/kg
    via imsingle dose1 doses total

    Combined with existentially oriented psychotherapy

Low dose ketamine

active comparator

Existentially oriented psychotherapy in combination with a low, non-hallucinogenic (non-psychedelic) dose of ketamine, acting as an active placebo.

Interventions

  • Ketamine0.2 mg/kg
    via imsingle dose1 doses total

    Combined with existentially oriented psychotherapy; described as an active placebo condition

Primary Results(1 publication)

Participants

N = 70Mean age: 21.6–23 across armsM. et al. 2002

Adverse Events (from all publications)

Arm / GroupnAny TEAESevereSeriousDiscont.
High dose ketamineexperimental3535(100.0%)0(0.0%)0(0.0%)0(0.0%)
Low dose ketamineactive_comparator3535(100.0%)0(0.0%)0(0.0%)0(0.0%)

* All subjects in this arm experienced an acute increase in systolic and diastolic blood pressure (20-30%) during the ketamine session. No other side effects or complications (including protracted psychosis or flashbacks) were noted.

Study Details

  • Status
    Completed
  • Type
    interventional
  • Design
    Randomizeddouble Blind
  • Target Enrollment70 participants
  • Timeline
    Start: 1998-01-01
    End: 2002-01-01
  • Compounds

Related Publications

Your Library

Ketamine Psychotherapy for Heroin Addiction:... — Clinical Trial Details | Blossom